Issued Patents 2022
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11505605 | T cell-redirected antigen-binding molecule for cells having immunosuppression function | Takahiro Ishiguro, Shimon Sakaguchi, Hiroyoshi Nishikawa | 2022-11-22 |
| 11485790 | Immunoactivating antigen-binding molecule | Taro Miyazaki, Kenji Taniguchi, Naoka Hironiwa | 2022-11-01 |
| 11454633 | Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use | Yoshinao Ruike, Taichi Kuramochi, Hiroyasu Muramatsu, Atsunori Ueyama, Hitoshi Katada +1 more | 2022-09-27 |
| 11400157 | Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusion | Naoka Hironiwa, Hiroki Kawauchi | 2022-08-02 |
| 11371039 | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly | Shinya Ishii, Atsuhiko Maeda, Takashi Nakai | 2022-06-28 |
| 11359194 | Antigen-binding molecule capable of binding two or more antigen molecules repeatedly | Shinya Ishii, Atsuhiko Maeda, Takashi Nakai | 2022-06-14 |
| 11332533 | Modified antibody constant region | Hirotake Shiraiwa | 2022-05-17 |
| 11274151 | CD3-targeting and DLL3-targeting multispecific antigen-binding molecules and uses thereof | Sotaro Naoi, Shu Feng, Shu Wen Samantha Ho | 2022-03-15 |
| 11267868 | Fc region variant | Futa Mimoto, Hitoshi Katada | 2022-03-08 |
| 11248053 | Method of modifying isoelectric point of antibody via amino acid substitution in CDR | Hiroyuki Tsunoda, Tatsuhiko Tachibana, Taichi Kuramochi | 2022-02-15 |
| 11243210 | Ion concentration-dependent binding molecule library | Shinya Ishii, Miho Funaki, Naoka Hironiwa, Shun Shimizu | 2022-02-08 |
| 11236168 | Mouse FcγammaRII-specific Fc antibody | Eriko MURATA, Futa Mimoto | 2022-02-01 |
| 11214623 | Antibody capable of neutralizing substance having activity alternative to function of coagulation factor VIII (FVIII) | Atsushi Muto, Takehisa Kitazawa, Tsukasa Suzuki | 2022-01-04 |